Guidelines for antithrombotic therapy in pediatric patients

Journal of Pediatrics

Volumn 132, Issue 4, 1998, Pages 575-588

  Andrew, M ^a   Michelson, A D ^a   Bovill, E ^a   Leaker, M ^a   Massicotte, M P ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BLOOD CLOT LYSIS; CHILD; DRUG EFFECT; GENETIC PREDISPOSITION; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEMOSTASIS; HETEROZYGOTE; HUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 0031924357     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(98)70343-9     Document Type: Article

References (149)

1. AD Michelson E Bovill M. Andrew Antithrombotic therapy in children Chest 108 1995 506S 522S
2. B Zoller P Svensson X He B. Dahlback Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1994 2521 2524
3. EL Mayer DW Jacobsen K. Robinson Homocysteine and coronary atherosclerosis J Am Coll Cardiol 27 1996 517 527
4. M Andrew M David M Adams K Ali R Anderson D Barnard Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE Blood 83 1994 1251 1257
5. K Deeg D Wolfel T. Rupprecht Diagnosis of neonatal aortic thrombosis by colour coded Doppler sonography Pediatr Radiol 22 1992 62 63
6. M Andrew L. Brooker Blood component therapy in neonatal hemostatic disorders Transf Med Rev 9 1995 231 250
7. B Dahlback B. Hildebrand Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V Proc Natl Acad Sci USA 91 1994 1396 1400
8. X Sun B Evatt JH. Griffin Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia Blood 83 1994 3120 3125
9. BPC Koeleman D van Rumpt K Hamulyak PH Reitsma RM. Bertina V Factor Leiden: an additional risk factor for thrombosis in protein S deficient families Thromb Haemost 74 1995 580 583
10. M Andrew B Paes R Milner M Johnston L Mitchell D Tollefsen Development of the human coagulation system in the full-term infant Blood 70 1987 165 172
11. M Andrew B Paes M. Johnston Development of the hemostatic system in the neonate and young infant Am J Pediatr Hematol Oncol 12 1990 95 104
12. M Andrew P Vegh M Johnston J Bowker F Ofosu L. Mitchell Maturation of the hemostatic system during childhood Blood 80 1992 1998 2005
13. MT Sifontes R Nuss LJ Jacobson JH Griffin MJ. Manco-Johnson Thrombosis in otherwise well children with the factor V Leiden mutation J Pediatr 128 1996 324 328
14. M Auletta J. Headington Purpura fulminans: a cutaneous manifestation of severe protein C deficiency Arch Dermatol 124 1988 1387 1391
15. A Estelles I Garcia-Plaza A Dasi J Aznar M Duart M Sanz Severe inherited protein C deficiency in a newborn infant Thromb Haemost 52 1984 53 56
16. M Dreyfus J Magny F Bridey H Schwarz C Planche M Dehan Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate N Engl J Med 325 1991 1565 1568
17. M Andrew J Halton M. Massicotte Treatment of homozygous protein C deficiency in two children with low molecular weight heparin (LMWH) therapy [abstract #154] Thromb Haemost 73 1995 939
18. R Marlar R Montgomery A Broekmans the working party Diagnosis and treatment of homozygous protein C deficiency J Pediatr 114 1989 528 534
19. V De Stefano G Leone M Carolis R Ferrelli S De Carolis L Pagano Antithrombin III in fullterm and preterm newborn infants: three cases of neonatal diagnosis of AT III congenital defect Thromb Haemost 57 1987 329 331
20. P Mannucci A Tripodi R Bertina Protein S Deficiency associated with “juvenile” arterial and venous thromboses Thromb Haemost 55 1986 440
21. L Perlmutt KE. Fellows Lower extremity deep vein thrombosis in children Pediatr Radiol 13 1983 266 268
22. M Stockwell M Adams M Andrew G Cameron M. Pai Central venous catheters for out-patient management of malignant disorders Arch Dis Child 58 1983 633 663
23. CH Pegelow M Narvaez SR Toledano J Davis C Oiticica D. Buckner Experience with a totally implantable venous device in children Am J Dis Child 140 1986 69 71
24. RA Moore KW McNicholas H Naidech S Flicker JD. Gallagher Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients Anesthesiology 62 1985 640 643
25. V Marzinotto M Adams P Pencharz P Burrows M. Andrew Catheter related thrombosis in children receiving home TPN: incidence, diagnosis, management Thromb Haemost 69 1993 1079 1082
26. M David M. Andrew Venous thromboembolism complications in children: a critical review of the literature J Pediatr 123 1993 337 346
27. JAJ Ryan RM Abel WM Abbott CC Hopkins TM Chesney R Colley Catheter complications in total parenteral nutrition: a prospective study of 200 consecutive patients N Engl J Med 290 1974 757 761
28. AJ Franzone BL Tucker LP Brennan RN Fine QR. Stiles Hemodialysis in children Arch Surg 102 1971 592 593
29. FS Idriss LR Nikaidok R King O. Swenson Arteriovenous shunts for hemodialysis in infants and children J Pediatr Surg 6 1971 639 644
30. C Burri FW. Ahnfeld The caval catheter 1978 Springer-Verlag Berlin 1
31. M Andrew V Marzinotto P Pencharz S Zlotkin P Burrows J Ingram A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home J Pediatr 126 1995 358 363
32. P Massicotte M Adams V Marzinotto L Brooker M. Andrew Low molecular weight heparin in pediatric patients with thrombotic disease: a dose finding study J Pediatr 128 1996 313 318
33. M Andrew L Brooker L. Mitchell Acquired antithrombin III deficiency secondary to asparaginase therapy in childhood acute lymphoblastic leukemia Blood Coagul Fibrinolysis 5 Suppl 1 1994 S24 S36
34. M Andrew L. Brooker Hemostatic complications in renal disorders of the young Pediatr Nephrol 10 1996 88 99
35. M Lallier D St Vil J Dubois K Paradis JM Laberge AL Bensoussan Vascular complications after pediatric liver transplantation J Pediatr Surg 30 1995 1122 1126
36. D Parient S Urvoas JY Riou S Tammam B Husson MH Bihet Imaging of complications of liver transplantation in children Ann Radiol (Paris) 37 1994 372 376
37. F Alvarez O Bernard F Brunelle P Hadchouel M Odievre D. Alagille Portal obstruction in children. II. Results of surgical portosystemic shunts J Pediatr 103 1983 703 707
38. DA Rouch JC Edmond M Ferrari D Yousefzadeh P Whitington CE. Broelsch The successful mangement of portal vein thrombosis after hepatic transplantation with a splenorenal shunt Surg Gynecol Obstet 166 1988 311 316
39. J Ward JA Spencer JA Guthrie PJ. Robinson Liver transplantation: dynamic contrast-enhanced magnetic resonance imaging of the hepatic vasculature Clin Radiol 51 1996 191 197
40. R Kane S. Eustace Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography Radiology 195 1995 117 121
41. E Skarsgard J Doski T Jaksic D Wesson B Shandling S Ein Thrombosis of the portal venous system after splenectomy for pediatric hematologic disease J Pediatr Surg 28 1993 1109 1112
42. F Brunelle D Pariente D Alagille P. Chaumont Ultrasound and protal hypertension in children: demonstration of gastro-oesophageal collaterals-preliminary report Ann Radiol (Paris) 61 1980 671 675
43. G Gollin B Ward GB Meier BE Sumpio RJ. Gusberg Central spanchnic venous thrombosis. Often unsuspected, usually uncomplicated J Clin Gastroenterol 18 1994 109 113
44. D Alarcon-Segovia M Deleze C Oria Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus Medicine 68 1989 353 365
45. DD Dungan MS. Jay Stroke in an early adolescent with systemic lupus erythematosus and coexistent antiphospholipid antibodies Pediatrics 90 1992 96 99
46. P Pelkonen O Simell V Rasi O. Vaarala Venous thrombosis associated with lupus anticoagulant and anticardiolipin antibodies Acta Paediatr Scand 77 1988 767 772
47. S Appan M Boey K. Lim Multiple thromboses in systemic lupus erythematosus Arch Dis Child 62 1987 739 741
48. ML Bernstein M Salusinsky-Sternbach M Bellefleur DW. Esseltine Thrombotic and hemorrhagic complications in children with the lupus anticoagulant Am J Dis Child 138 1984 1132 1135
49. D Olive E Andre O Brocard P Labrude P. Alexandre Lupus erythemateux dissemine revele par des thrombophlebites des membres inferieurs Arch Franc Pediatr 36 1979 807 811
50. PA Ostuni P Lazzarin V Pengo A Ruffatti F Schiavon P. Gambari Renal artery thrombosis and hypertension in a 13 year old girl with antiphospholipid syndrome Ann Rheum Dis 49 1990 184 187
51. T Kwong J Leonidas N. Ilowite Asymptomatic superior vena cava thrombosis and pulmonary embolism in an adolescent with SLE and antiphospholipid antibodies Clin Exp Rheumatol 12 1994 215 217
52. L Rider W Clarke J. Rutledge Pulmonary hypertension in a seventeen-year-old boy J Pediatr 120 1992 149 159
53. C Berube M David R Laxer E Silverman C St-Cyr M Adams The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus in children: a cross-sectional study Lupus 3 1994 360A
54. E von Scheven BH Athreya C Rose DP Goldsmith L. Morton Clinical characteristics of antiphospholipid antibody syndrome in children J Pediatr 129 1996 339 345
55. R Green T Meyer M Dunn J. Glassroth Pulmonary embolism in younger adults Chest 101 1992 1507 1511
56. D Bernstein S Coupey S. Schonberg Pulmonary embolism in adolescents Am J Dis Child 140 1986 667 671
57. J Carson M Kelley A Duff J Weg W Fulkerson H Palevsky The clinical course of pulmonary embolism N Engl J Med 326 1992 1240 1245
58. JR Buck RH Connors WW Coon WH Weintraub JR Wesley AG. Coran Pulmonary embolism in children J Pediatr Surg 16 1981 385 391
59. R Hull G Raskob J Hirsh Continuous intravenous heparin compared to intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis N Engl J Med 315 1986 1109 1114
60. Aggressive or conservative treatment in subclavian vein thrombosis B Lindblad D Bergqvist B Eklof J Gjores O Thulesius D Bergqvist Controversies in the management of venous disorders. 1989 Butterworth London 141 158
61. NJC Swinton JJM Edgett R. Hall Primary subclavian-axillary vein thrombosis Circulation 38 1968 737 745
62. M Leaker MP Massicotte L Brooker M. Andrew Thrombolytic therapy in pediatric patients: a comprehensive review of the literature Thromb Haemost 76 1996 132 134
63. T Hall S McDiarmid E Grant M Boechat R. Bosulti False-negative duplex Doppler studies in children with hepatic artery thrombosis after liver transplantation AJR Am J Roentgenol 154 1990 573 575
64. E Flint J Sumkin A Zajko A. Bowen Duplex sonography of hepatic artery thrombosis after liver transplantation AJR Am J Roentgenol 151 1988 481 483
65. G Koren V Rose S Lavi R. Rowe Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease JAMA 254 1985 767 769
66. A. Martini Behcet's disease and Takayasu's arteritis Curr Opin Rheumatol 7 1995 449 454
67. M Freed J Keane A. Rosenthal The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children Circulation 50 1974 565 569
68. M Freed A Rosenthal D. Fyler Attempts to reduce arterial thrombosis after cardiac catheterization in children: use of percutaneous technique and aspirin Am Heart J 87 1974 283 286
69. H. Taussig Long-time observations on the Blalock-Taussig operation. IX. Single ventricle (with apex to the left) Johns Hopkins Med J 139 1976 69 76
70. D Tamisier P Vouhe F Vernant F Leca C Massot J. Neveux Modified Blalock-Taussig shunts: results in infants less than 3 months of age Ann Thorac Surg 49 1990 797 801
71. V Bjork C Olin B Bjarke C. Thoren Right atrial-right ventricular anastomosis for correction of tricuspid atresia J Thorac Cardiovasc Surg 77 1979 452 458
72. E Zahn V Lima L Benson R. Freedom Use of endovascular stents to increase pulmonary blood flow in pulmonary atresia with ventricular septal defect Am J Cardiol 70 1992 411 412
73. S Peeters Y Vandenplas K Jochmans A Bougatef M De Waele D. De Wolf Myocardial infarction in a neonate with hereditary antithrombin III deficiency Acta Paediatr 82 1993 610 613
74. G Whittlesey D Drucker S Salley H Smith S Kundu S Palder ECMO without heparin: laboratory and clinical experience J Pediatr Surg 26 1991 320 325
75. G Zobel M Trop W Muntean E Ring H. Gleispach Anticoagulation for continuous arteriovenous hemofiltration in children Blood Purif 6 1988 90 95
76. S Suarez A. Paller Atrophie blanche with onset in childhood J Pediatr 123 1993 753 755
77. D Hsu L Addonizio A Hordof W. Gersony Acute pulmonary embolism in pediatric patients awaiting heart transplantation J Am Coll Cardiol 17 1991 1621 1625
78. J. Hirsh Heparin N Engl J Med 324 1991 1565 1574
79. L Mitchell F Piovella F Ofosu M. Andrew Alpha-2-Macroglobulin may provide protection from thromboembolic events in antithrombin III deficient children Blood 78 1991 2299 2304
80. M Andrew L Mitchell P Vegh F. Ofosu Thrombin regulation in children differs from adults in the absence and presence of heparin Thromb Haemost 72 1994 836 842
81. M Andrew F Ofosu B Schmidt L Brooker J Hirsh M. Buchanan Heparin clearance and ex vivo recovery in newborn piglets and adult pigs Thromb Res 52 1988 517 527
82. B Schmidt F Ofosu L Mitchell L Brooker M. Andrew Anticoagulant effects of heparin in neonatal plasma Pediatr Res 25 1989 405 408
83. M Andrew V Marzinotto V Blanchette J Ginsberg P Burrows L Benson Heparin therapy in pediatric patients: a prospective cohort study Pediatr Res 35 1994 78 83
84. M Cruickshank M Levine J Hirsh R Roberts M. Siguenza A standard heparin nomogram for the management of heparin therapy Arch Intern Med 151 1991 333 337
85. A Zipursky M Johnston D deSa E Hsu R. Milner Clinical and laboratory diagnosis of hemostatic disorders in newborn infants Am J Pediatr Hematol Oncol 1 1979 217 226
86. E Melissari CJ Parker NV Wilson G Monte C Kanthou KD Pemberton Use of low molecular weight heparin in pregnancy Thromb Haemost 68 1992 652 656
87. I Murdoch R Beattie D. Silver Heparin-induced thrombocytopenia in children Acta Paediatr 82 1993 495 497
88. D Spadone F Clark E James J Laster J Hoch D. Silver Heparin-induced thrombocytopenia in the newborn J Vasc Surg 15 1992 306 311
89. B Boneu MR Buchanan C Caranobe AM Gabaig D Dupouy P Sie The disappearance of a low molecular weight heparin fraction (CY216) differs from standard heparin in rabbits Thromb Res 46 1987 845 853
90. L Andersson T Barrowcliffe E Holmer E Johnson G. Sims Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration Thromb Res 9 1976 575 583
91. E Johnson T Kirkwood Y Stirling J Perez-Requejo G Ingram D Bangham Four heparin preparations: anti-Xa potentiating effects of heparin after subcutaneous injection Thromb Haemost 35 1976 586 591
92. J Hirsh M. Levine Low molecular weight heparin Blood 79 1992 1 17
93. D Lane I MacGregor R Ivan G Cella V. Kakkar Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man Thromb Res 16 1979 651 662
94. D Bergqvist U Hedner E Sjorin E. Holmer Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously Thromb Res 32 1983 381 391
95. M Palm C. Mattsson Pharmacokinetics of fragmin: a comparative study in the rabbit of its high and low affinity forms for antithrombin Thromb Res 48 1987 51 62
96. J. Hirsh Oral anticoagulant drugs: review article N Engl J Med 324 1991 1865 1875
97. E Loeliger A van den Besselaar S Lewis Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control Thromb Haemost 53 1985 148 154
98. L. Poller Progress in standardization anticoagulation control Hematol Rev 1 1987 225 241
99. L. Poller Laboratory control of oral anticoagulants BMJ 294 1987 1184
100. International Committee for Standardization in Haematology International Committee on Thrombosis and Haemostasis ICSH/ICTH Recommendations for reporting prothrombin time in oral anticoagulant control Thromb Haemost 53 1985 155 156
101. J Hirsh L Poller D Deykin M Levine JE. Dalen Optimal therapeutic range for oral anticoagulants Chest 95 1989 5S 11S
102. M Andrew V Marzinotto L Brooker M Adams J Ginsberg R Freedom Oral anticoagulant therapy in pediatric patients: a prospective study Thromb Haemost 71 1994 265 269
103. U Carpentieri QX Nghiem LC. Harris Clinical experience with an oral anticoagulant in children Arch Dis Child 51 1976 445 448
104. A Aballi S. de Lamerens Coagulation changes in the neonatal period and in early infancy Pediatr Clin North Am 9 1962 785 817
105. 1 in mothers and their newborn babies Lancet 2 1982 460 463
106. S Kumar J Haigh L Rhodes S Peaker J Davies B Roberts Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy Thromb Haemost 62 1989 729 732
107. S Stewart D Cianciotta C Alexson J. Manning The long-term risk of warfarin sodium therapy and the incidence of thromboembolism in children after prosthetic cardiac valves J Thorac Cardiovasc Surg 93 1987 551 554
108. P Kornblit J Senderoff M Davis-Ericksen J. Zenk Anticoagulation therapy: patient management and evaluation of an outpatient clinic Nurse Pract 15 1990 21 32
109. S Cortelazzo G Finazzi P Viero M Galli A Remuzzi L Parenzan Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic Thromb Haemost 69 1993 316 320
110. GW Petty L Lennihan JP Mohr WA Hauser J Weitz J Owen Complications of long-term anticoagulation Ann Neurol 23 1988 570 574
111. SM Garabedian-Ruffalo DR Gray MJ Sax RL. Ruffalo Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic Am J Hosp Pharm 42 1985 304
112. R Ellis M Stephens G. Sharp Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy Am J Hosp Pharm 49 1992 387 394
113. P Massicotte V Marzinotto P Vegh M Adams M. Andrew Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor J Pediatr 127 1995 389 394
114. Practical dosing considerations with warfarin and optimal therapeutic range J Hirsh L Poller Oral anticoagulants. 1996 Arnold London 167 179
115. WE. Hathaway Use of antiplatelet agents in pediatric hypercoagulable states Am J Dis Child 138 1984 301 304
116. A Serra K McNicholas HJ Olivier S Boe G. Lemole The choice of anticoagulation in pediatric patients with the St. Jude Medical valve prostheses J Cardiovasc Surg 28 1987 588 591
117. L McGrath L Gonzalez-Lavin W Edlredge M Colombi D. Restrepo Thromboembolic and other events following valve replacement in a pediatric population treated with antiplatelet agents Ann Thorac Surg 43 1987 285 287
118. LM Bradley FM Midgley DC Watson Anticoagulation therapy in children with mechanical prosthetic cardiac valves Am J Cardiol 56 1985 533 535
119. S Rao L Solymar M Mardini M Fawzy G. Guinn Anticoagulant therapy in children with prosthetic valves Ann Thorac Surg 47 1989 589 592
120. L Solymar PS Rao MK Mardini ME Fawzy G. Guinn Prosthetic valves in children and adolescents Am Heart J 121 1991 557 568
121. AM Borkon L Soule BA Reitz VL Gott TJ. Gardner Five year follow-up after valve replacement with the St. Jude Medical valve in infants and children Circulation 74 suppl I 1986 I-110 I-115
122. J LeBlanc S Sett D. Vince Antiplatelet therapy in children with left-sided mechanical prostheses Eur J Cardiothorac Surg 7 1993 211 215
123. JS Partin JC Partin WK Schubert JG. Hammond Serum salicylate concentrations in Reye's disease Lancet 1 8265 1982 191 193
124. K Starko C Ray L Dominguez W Stromberg D. Woodall Reye's syndrome and salicylate use Pediatrics 66 1980 859 864
125. J Corrigan J Sluth M Jeter C. Lox Newborn's fibrinolytic mechanism: Components and plasmin generation Am J Hematol 32 1989 273 278
126. M Leaker L Brooker L Mitchell J Weitz R Superina M. Andrew Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric patients undergoing orthotopic liver transplantation Transplantation 60 1995 144 147
127. M Leaker R Superina M. Andrew Fibrin clot lysis by tissue plasminogen activator (tPA) is impaired in plasma from pediatric liver transplant patients Transplantation 60 1995 144 147
128. M Andrew L Brooker B Paes J. Weitz Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration Thromb Haemost 68 1992 325 330
129. B Kellam D Fraze K. Kanarek Clot lysis for thrombosed central venous catheters in pediatric patients J Perinatol 7 1987 242 244
130. JJ Mirro BN Rao DC Stokes BA Austin M Kumar GV Dabe A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients J Clin Oncol 7 1989 214 222
131. TM Hyers RD Hull JC. Weg Antithrombotic therapy for venous thromboembolic disease Chest 108 1995 335S 351S
132. A Woods J Vargas G Berri G Kreutzer S Meschengieser MA. Lazzari Antithrombotic therapy in children and adolescents Thromb Res 42 1986 289 301
133. JJ Doyle G Koren MY Chen VS. Blanchette Anticoagulation with sodium warfarin in children: effect of a loading regimen J Pediatr 113 1988 1095 1097
134. D Evans M Rowlands L. Poller Survey of oral anticoagulant treatment in children J Clin Pathol 45 1992 707 708
135. MM Bern JJ Lokich SR Wallach AJ Bothe PN Benotti CF Arkin Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial Ann Intern Med 112 1990 423 428
136. B Schmidt M. Andrew Report of scientific and standardization subcommittee on neonatal hemostasis diagnosis and treatment of neonatal thrombosis Thromb Haemost 67 1992 381 382
137. P Spevak M Freed A Castaneda WI Norwood P. Pollack Valve replacement in children less than 5 years of age J Am Cardiol 8 1986 901 908
138. A El Makhlouf B Friedli I Oberhansli Prosthetic heart valve replacement in children J Thorac Cardiovasc Surg 93 1987 80 85
139. Y Harada Y Imai H Kurosawa K Ishihara M Kawada S. Fukuchi Ten-year follow-up after valve replacement with the St. Jude Medical prosthesis in children J Thorac Cardiovasc Surg 100 1990 175 180
140. A Milano PR Vouhe F Baillot-Vernant P Donzeau-Gouge F Trinquet P Roux Late results after left-sided cardiac valve replacement in children J Thorac Cardiovasc Surg 92 1986 218 225
141. MS Schaffer DR Clarke DN Campbell CK Madigan JW Wiggins Jr RR. Wolfe The St. Jude Medical cardiac valve and children: role of anticoagulant therapy J Am Coll Cardiol 9 1987 235 239
142. H Schaff G Danielson R DiDonato F Puga D Mair D. McGoon Late results after Starr-Edwards valve replacement in children J Thorac Cardiovasc Surg 88 1984 583 589
143. DG Human HS Joffe CB Fraser CN. Barnard Mitral valve replacement in children J Thorac Cardiovasc Surg 83 1982 873 877
144. MJ Antunes KM Vanderdonck MJ. Sussman Mechanical valve replacement in children and teenagers Eur J Cardiothorac Surg 3 1989 222 228
145. P Stein D Grandison T Hua Therapeutic levels of oral anticoagulation with warfarin in patients with mechanical prosthetic heart valves: review of literature and recommendations based on International Normalized Ratio Postgrad Med J 70 Suppl 1 1994 S72 S83
146. A Turpie M Gent A Laupacis Comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement N Engl J Med 329 1993 524 529
147. A Turpie J Gunstensen J Hirsh H Nelson M. Gent Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement Lancet 1 1988 1242 1245
148. S Daniels P Specker TE Capannari D Schwartz M Burke S. Kaplan Correlates of coronary artery aneurysm formation in patients with Kawasaki disease Am J Dis Child 141 1987 205 207
149. D Cook G Guyatt A Laupacis D Sackett R. Goldberg Clinical recommendations using levels of evidence for antithrombotic agents Chest 108 suppl 1995 227S 230S